|
The IMF Super Friday Program at the 50th ASH Annual Meeting and Exposition on December 5 at the Moscone Center in San Francisco. This CME-certified symposium will provide an overview of the most recent data from clinical trials, focusing on key findings supporting the use of novel therapeutic approaches for treating multiple myeloma in both the frontline and relapsed settings. The program consists of both didactic and case-based presentations. This program is sponsored by the Postgraduate Institute for Medicine and supported by the International Myeloma Foundation. View the Event Website here.
SPEAKERS | 
| Brian G.M. Durie, MD
Cedars-Sinai Comprehensive Cancer Center
Los Angeles, CA |
| 
| Antonio Palumbo, MD
University of Turin
Turin, Italy |
| 
| S. Vincent Rajkumar, MD
Mayo Clinic College of Medicine
Rochester, MN |
| 
| Jesus San Miguel, MD, PhD
Hospital Universidad de Salamanca
Salamanca, Spain |
AGENDA
6:00 PM - 9:00 PM
6:00 PM - 6:30 PM Registration and Dinner
6:30 PM - 6:40 PM Welcome and Introduction/ARS Demographic Questions
Brian G. M. Durie, MD, Program Director6:40 PM - 7:10 PM Case Study 1: A Multiple Myeloma Patient Ineligible for Transplantation
- Overview and ARS Questions:
Brian G. M. Durie, MD - Evidence-Based Approaches for Induction Therapy:
Antonio Palumbo, MD - Panel Discussion and Question and Answer Session
7:10 PM - 7:40 PM Case Study 2: A Transplantation-Eligible Multiple Myeloma Patient
- Overview and ARS Questions:
Brian G. M. Durie, MD - Evidence-Based Approaches for Transplantation-Eligible Patients:
Thierry Facon, MD - Panel Discussion and Question and Answer Session
7:40 PM - 8:10 PM Case Study 3: A Multiple Myeloma Patient for Whom Transplantation Eligibility Is Uncertain
- Overview and ARS Questions:
Brian G. M. Durie, MD - Considerations in Determining Transplantation Eligibility:
Vincent Rajkumar, MD - Panel Discussion and Question and Answer Session
8:10 PM - 8:40 PM Case Study 4: A Multiple Myeloma Patient Who Relapses Following Induction Therapy
- Overview and ARS Questions:
Brian G. M. Durie, MD - Current Issues in Determining Therapy for Relapsed/Refractory Multiple Myeloma:
Jesus San Miguel, MD, PhD - Panel Discussion and Question and Answer Session
8:40 PM - 9:00 PM Conclusion
- Faculty Panel Commentary, Recommendations, Question and Answer Session
- Concluding Remarks
Brian G. M. Durie, MD |
print